Supply and procurement

in page functions

Documents related to Gavi's supply and procurement strategy that aims to ensure sufficient and uninterrupted supply of high-quality vaccines, promote low and sustainable costs for developing countries, and foster an environment for innovation

06 October 2017

Consolidated comments from the public consultation on externalities of Gavi market shaping activities

In June 2017, Gavi, the Vaccine Alliance launched a public consultation process on externalities of market shaping. The consultation was open from 26 June 2017 to 02 August 2017. This document provides an overview of the process, as well as a summary of the main themes that emerged from the comments received. It does not necessarily reflect the views of Gavi, the Vaccine Alliance.

11 August 2017

IPV Roadmap Public Summary

In 2013, the GAVI Board decided to begin supporting the introduction of inactivated polio vaccine (IPV) as part of routine immunisation programmes in the world’s 73 poorest countries. This document is the public summary of the supply and procurement roadmap for IPV, which supports the Alliance’s efforts to achieve our market shaping goal – to shape vaccine markets to ensure adequate supply of appropriate, quality vaccines at low and sustainable prices for developing countries.

08 May 2017

Gavi Base Demand Forecast

The Base Demand Forecast summarises actual and forecasted volumes for eleven vaccines that Gavi supports. The volumes presented are from the demand forecast used to inform the Gavi Financial forecast.

04 May 2017

Healthy markets framework: public overview

Gavi, the Vaccine Alliance, developed the Healthy Markets Framework (HMF) as a tool to support market shaping.

27 April 2017

Rotavirus Roadmap Public Summary

Rotavirus is the leading cause of severe diarrhoea in children under five years of age worldwide. This document is the public summary of the supply and procurement roadmap for rotavirus vaccine.

21 April 2017

Ice-lined (ILR) and Solar Direct Drive (SDD) refrigerators/freezers: public summary

Gavi established the Cold Chain Equipment Optimisation Platform (CCEOP) in June 2015 as a strategic and targeted approach to address the challenges of improving the vaccine cold chain with higher-performing equipment. This document provides a summary of the supply and procurement roadmap for two CCE product categories : Ice-lined (ILR) & Solar Direct Drive (SDD) refrigerators/ freezers.

12 April 2017

Pneumococcal vaccine roadmap: public summary

Gavi has supported routine introductions with pneumococcal vaccine since 2009. Find out more about the pneumococcal vaccine market, and Gavi’s approach to shaping it, in the public summary of the vaccine supply and procurement roadmap.

06 April 2017

Detailed product profiles

Detailed product profiles (DPPs) give countries easy access to up-to-date and comprehensive information on Gavi-supported vaccines. They also provide an overview of all WHO prequalified products for vaccine groups that Gavi supports.

04 April 2017

Penta Roadmap Public Summary

The development of hepatitis B (hepB) and Haemophilus influenzae type b (Hib) vaccination through the uptake of pentavalent routine immunization represents the most significant Gavi achievement to date.

20 March 2017

Yellow Fever Roadmap Public Summary

Gavi has been engaged in Yellow Fever (YF) vaccination since 2001 in support of WHO efforts to control the disease. This document is the public summary of the supply and procurement roadmap for Yellow Fever vaccine.

13 January 2017

Supply and Procurement Strategy 2016-20: Overview

Gavi’s Supply and Procurement Strategy describes the Alliance’s activities towards strategic goal 4 (SG4), to shape markets for vaccines and other immunisation products, to the benefit of the countries that Gavi supports. This document provides a short overview of the strategy.

21 December 2016

Product Portfolio Management

As part of the Supply and Procurement Strategy 2016-20, the Gavi Board approved a set of principles which guides decisions on when to offer support for a specific vaccine or other immunisation product through an open funding window.

11 October 2016

12 September 2016

Japanese encephalitis vaccine roadmap: public summary

Gavi, the Vaccine Alliance opened a funding window for Japanese encephalitis (JE) vaccination catch-up campaigns in endemic countries at its November 2013 Board meeting. This document is the public summary of the supply and procurement roadmap for JE, which supports the Alliance’s efforts to achieve our market shaping goal – to shape vaccine markets to ensure sufficient, secure supply of suitable, quality vaccines at appropriate and sustainable prices for developing countries.

19 August 2016

27 July 2016

Supply and Procurement Strategy 2016-20

Gavi’s Supply and Procurement Strategy describes the Alliance’s activities towards strategic goal 4 (SG4), to shape markets for vaccines and other immunisation products, to the benefit of the countries that Gavi supports.

24 June 2015

01 April 2015

Meningococcal Roadmap Public Summary

Gavi is engaged in meningococcal vaccine to eliminate serogroup A meningococcal meningitis (MenA) epidemics as a public health problem in Africa. This document is the public summary of the supply and procurement roadmap for menigococcal vaccine, which supports the Alliance’s efforts to achieve our market shaping goal – to shape vaccine markets to ensure adequate supply of appropriate, quality vaccines at low and sustainable prices for developing countries.

31 January 2015

31 January 2015

FAQ: Janssen Pharmaceuticals pricing commitments for countries transitioning out of Gavi’s financial support

Vaccine price commitments from Janssen Pharmaceuticals – January 2015.

31 January 2015

01 December 2014

Cholera Roadmap Public Summary

Gavi is funding the procurement of oral cholera vaccine from 2014-2018 via the existing cholera vaccine stockpile, managed by the International Coordination Group (ICG). This document is the public summary of the supply and procurement roadmap for cholera vaccine, which supports the Alliance’s efforts to achieve our market shaping goal – to shape vaccine markets to ensure adequate supply of appropriate, quality vaccines at low and sustainable prices for developing countries.

07 July 2014

Measles-rubella vaccine roadmap: public summary

The GAVI Alliance began funding measles-rubella (MR) vaccine catch-up campaigns iin 2011. This document is the public summary of the supply and procurement roadmap for MR, which supports the Alliance’s efforts to achieve our market shaping goal – to shape vaccine markets to ensure adequate supply of appropriate, quality vaccines at low and sustainable prices for developing countries.

30 October 2012

HPV Supply and Procurement Roadmap

HPV Supply and Procurement Roadmap www.gavialliance.org UPDATE 2012 1 PUBLIC SUMMARY Supply and Procurement Roadmap HPV (Human Papilloma Virus) Vaccine The market-shaping goal Shape vaccine markets to provide appropriate and affordable vaccines HPV Supply and Procurement Roadmap www.gavialliance.org UPDATE 2012 2 The G

30 October 2012

GAVI Vaccine Supply and Procurement Strategy 2011-2015

1 The GAVI Alliance Vaccine Supply and Procurement Strategy for the period 2011-2015 VERSION NUMBER APPROVAL PROCESS DATE 1.0 Reviewed by: GAVI Programme and Policy Committee 28 September 2011 Approved by: GAVI Alliance Board 17 November 2011 Effective from: approval date Review: in 2014, in preparation for the develop

01 September 2011

Consolidated comments from public consultation on GAVI’s draft Vaccine Supply and Procurement Strategy

In July 2011 the GAVI Secretariat launched a public consultation process on the draft Vaccine Supply and Procurement Strategy for 2011-2015. The consultation was open from 4 to 29 July 2011. This document provides an overview of the process, as well as a summary of the main themes that emerged from the comments received.

07 July 2011

GAVI Alliance’s Draft Vaccine Supply and Procurement Strategy 2011-2015: for public comments

In order to achieve its market shaping objectives, GAVI is redesigning its vaccine supply and procurement strategy. This document outlines the objectives and strategies, and describes the supply and procurement mechanisms by which the new strategy will be effected.

04 July 2011

GAVI Alliance’s Draft Vaccine Supply and Procurement Strategy 2011-2015: background information

This document provides background information to GAVI's Draft Vaccine Supply and Procurement Strategy for the period 2011-2015, made available for public consultation.

29 April 2011

GAVI Procurement Principles

GAVI recognizes immunisation as an important and potentially cost-effective intervention that can enhance the right of all children to a healthy life, that has positive effects in combating poverty and that is a critical contribution to the achievement of public health gains.

06 December 2005

Supply Strategy for Hib and HepB Containing Vaccines

Recommendations and analysis of the GAVI supply strategy task team for a supply and procurement stragety for Hib and HebB containing vaccines during the GAVI Board meeting, 6-7 December 2005, in Delhi, India.

28 June 2002

Mercer Report on Vaccine Procurement

Summary of the findings of a study commissioned by the Vaccine Fund and the GAVI FInancing Task Force Procurement Sub-group to examine the first procurement of vaccines by GAVI and the Vaccine Fund.

 



close icon

modal window here